Samantha Semenkow

Stock Analyst at Citigroup

(0)
# 4911
Out of 5,441 analysts
53
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
WVE WAVE Life Sciences
Initiates Coverage On: Buy
16
8.11 97.29% 1 Jul 16, 2025
PRME Prime Medicine
Downgrades: Neutral
10 2
3.51 -57.26% 3 May 27, 2025
CABA Cabaletta Bio
Maintains: Buy
17 13
1.32 884.85% 3 May 16, 2025
ALLO Allogene Therapeutic...
Maintains: Buy
8 4
1.03 288.35% 3 May 15, 2025
ARGX argenx
Maintains: Strong Buy
796 803
638.76 25.71% 6 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
17.5 242.86% 1 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 5
4.34 15.21% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 3
2.27 32.16% 2 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
3.08 289.61% 1 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 31
19.69 57.44% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 15
2.9 417.24% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
80
7.48 969.52% 2 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 14
3.79 269.39% 6 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 15
2.2 581.82% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 12
5 140% 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
72
53.36 34.93% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
56.99 -19.28% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
33 50
14.76 238.75% 3 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 56
17.16 226.34% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 1
n/a n/a 3 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.54 289.61% 1 May 3, 2023